Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 19 Mar 2026 for Biomarin Pharmaceutical INC, €83k. Read the official filing
Filing timeline
BuySaleCharles Greg Guyer
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles Greg Guyer: trading record in brief
Charles Greg Guyer (chief executive) discloses dealings in Biomarin Pharmaceutical Inc to SEC (Form 4). Between 30 April 2021 and 17 March 2026, the trades on record add up to 20 filings.
The open-market record consists of 4 sales worth €2.4M, with no purchase. Besides market trades, the filings include 16 share grants. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 19 March 2026, reports a share grant of €83k in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles Greg Guyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,693 shares@ US$56.052.5% of flowCommon StockSEC:0001628280-26-019857:0
9,109 shares@ US$58.5112.5% of flowCommon StockSEC:0001628280-26-019012:0
16,486 shares@ US$60.4618.8% of flowCommon StockSEC:0001628280-26-017447:0
6,176 shares0Common StockSEC:0001628280-26-012542:0
20,127 shares@ US$69.4440.6% of flowCommon StockSEC:0001048477-25-000031:0
7,034 shares@ US$71.27614.7% of flowCommon StockSEC:0001048477-25-000025:0
4,287 shares@ US$71.169.3% of flowCommon StockSEC:0001048477-25-000021:0
11,040 shares0Common StockSEC:0001048477-25-000017:0
55 shares@ US$56.0070.1% of flowCommon StockSEC:0001048477-24-000154:0
245 shares@ US$68.6460.5% of flowCommon StockSEC:0001048477-24-000077:0
10,550 shares0Common StockSEC:0001048477-24-000046:0
20,840 shares0Common StockSEC:0001048477-24-000024:0
133 shares@ US$69.2330.3% of flowCommon StockSEC:0001048477-23-000051:0
5,360 shares@ US$93.30414.4% of flowCommon StockSEC:0001048477-23-000035:0
239 shares@ US$66.880.5% of flowCommon StockSEC:0001209191-23-027934:0
8,900 shares0Common StockSEC:0001567619-23-005299:0
6,205 shares@ US$96.5618.5% of flowCommon StockSEC:0001567619-22-015499:0
243 shares@ US$62.4070.0001% mcap38.8% of flowCommon StockSEC:0001567619-22-009719:0
11,040 shares0Common StockSEC:0001567619-22-007183:0
221 shares@ US$62.4070.2% of flowCommon StockSEC:0001567619-21-009154:0
20 of 20 declarations
